Abstract:
Un compuesto de fórmula (I): **(Ver fórmula)** o sales del mismo, en donde **(Ver fórmula)** A, una cabeza hidrófila, es en el que cada uno de Ra, Ra', Ra" y Ra'", independientemente, es H, un radical alifático monovalente C1-C20, un radical heteroalifático monovalente C1-C20, un radical de arilo monovalente o un radical de heteroarilo monovalente; y Z es un radical alifático bivalente C1-C20, un radical heteroalifático bivalente C1-C20, un radical de arilo bivalente o un radical de heteroarilo bivalente; o A se selecciona de las siguientes estructuras: **(Ver fórmula)** B es**(Ver fórmula)** en el que R4, R5, R6, e Y se definen a continuación; cada uno de R1 y R4, independientemente, es un radical alifático bivalente C1-C10, un radical heteroalifático bivalente C1-C10, un radical de arilo bivalente o un radical de heteroarilo bivalente; cada uno de R2 y R5, independientemente, es un radical alifático bivalente C1-C20, un radical heteroalifático bivalente C1-C20, un radical de arilo bivalente o un radical de heteroarilo bivalente; cada uno de R3 y R6, independientemente, es un radical alifático monovalente C1-C20, un radical heteroalifático monovalente C1-C20, un radical de arilo monovalente o un radical de heteroarilo monovalente; cada uno de átomos de carbono; y una cola hidrófoba, y también una cola hidrófoba, tiene de 8 a 24 cada uno de X, un conector, e Y, también un conector, independientemente, es **(Ver fórmula)** en el que cada uno de m, n, p, q y t, independientemente, es de 1-6; W es O, S o NRc; cada uno de L1, L3, L5, L7, y L9, independientemente, es un enlace, O, S o NRd; cada uno de L2, L4, L6, L8, y L10, independientemente, es un enlace, O, S o NRe; y V es ORf, SRg, o NRhRi, siendo cada uno de Rb, Rc, Rd, Re, Rf, Rg, Rh y Ri, independientemente, H, OH, radical oxialifático C1-C10, radical alifático monovalente C1-C10, radical heteroalifático monovalente C1-C10, un radical de arilo monovalente o un radical de heteroarilo monovalente, en donde los radicales de arilo y heteroarilo pueden incluir sustituyentes seleccionados de alquilo C1-C10, alquenilo C2-C10, alquinilo C2-C10, cicloalquilo C3-C20, cicloalquenilo C3-C20, heterocicloalquilo C3-C20, heterocicloalquenilo C3- C20, alcoxilo C1-C10, arilo, ariloxilo, heteroarilo, heteroariloxilo, amino, alquilamino C1-C10, dialquilamino C2-C20, arilamino, diarilamino, alquilsulfonamino C1-C10, arilsulfonamino, alquilimino C1-C10, arilimino, alquilsulfonimino C1-C10, arilsulfonimino, hidroxilo, halo, tio, alquiltio C1-C10, ariltio, alquilsulfonilo C1-C10, arilsulfonilo, acilamino, aminoacilo, aminotioacilo, amido, amidino, guanidina, ureido, tioureido, ciano, nitro, nitroso, azido, acilo, tioacilo, aciloxilo, carboxilo y éster carboxílico, y en donde los radicales alifáticos y heteroalifáticos pueden incluir sustituyentes seleccionados de alquenilo C2-C10, alquinilo C2-C10, cicloalquilo C3-C20, cicloalquenilo C3-C20, heterocicloalquilo C3-C20, heterocicloalquenilo C3-C20, alcoxilo C1-C10, arilo, ariloxilo, heteroarilo, heteroariloxilo, amino, alquilamino C1-C10, dialquilamino C2-C20, arilamino, diarilamino, alquilsulfonamino C1-C10, arilsulfonamino, alquilimino C1-C10, arilimino, alquilsulfonimino C1-C10, arilsulfonimino, hidroxilo, halo, tio, alquiltio C1-C10, ariltio, alquilsulfonilo C1-C10, arilsulfonilo, acilamino, aminoacilo, aminotioacilo, amido, amidino, guanidina, ureido, tioureido, ciano, nitro, nitroso, azido, acilo, tioacilo, aciloxilo, carboxilo y éster carboxílico.
Abstract:
A compound of formula the following formula:
In this formula, moieties A, B, X, Ri, R 2 , and R 3 are defined herein. Also disclosed are a nanocomplex that is formed of such a compound and a pharmaceutical agent, and a nanocomplex that is formed of a protein and a bioreducible compound.
Abstract:
A compound of formula the following formula:
In this formula, moieties A, B, X, Ri, R 2 , and R 3 are defined herein. Also disclosed are a nanocomplex that is formed of such a compound and a pharmaceutical agent, and a nanocomplex that is formed of a protein and a bioreducible compound.
Abstract:
A compound of formula the following formula: (I). In this formula, moieties A, B, X, R1, R2, and R3 are defined herein. Also disclosed are a nanocomplex that is formed of such a compound and a pharmaceutical agent, and a nanocomplex that is formed of a protein and a bioreducible compound.
Abstract:
A compound of formula the following formula: (I). In this formula, moieties A, B, X, R1, R2, and R3 are defined herein. Also disclosed are a nanocomplex that is formed of such a compound and a pharmaceutical agent, and a nanocomplex that is formed of a protein and a bioreducible compound.
Abstract:
Methods for fabricating nanostructures and articles associated therewith are described. In some embodiments, an isolated nanostructure (e.g., a metal nanowire) or an array of nanostructures can be fabricated by depositing a material (e.g., a metal) on a surface having a plurality of protrusions or indentations. At least a portion of the deposited material may be embedded in an encapsulating material, and the encapsulating material can be cut, for instance, to form a thin slice that includes the deposited material at least partially embedded therein. In some instances, the slice can be positioned on a surface in a desired arrangement. The encapsulating material can be removed from the surface to form one or more isolated nanostructures of the deposited material. Advantageously, dimensions of the nanostructures can be controlled to, e.g., 15 run, to form nanostructures having a variety of shapes and geometries (e.g., wires, rings, and cylinders). Nanostructures can also be formed in a variety of materials, including metals, ceramics, and polymers. In addition, nanostructures can also be fabricated over large areas (e.g., greater than 1 mm 2 ). In some cases, these nanostructures are positioned in association with other components, e.g., to form a functional component of a device.
Abstract:
The disclosure includes non-naturally occurring or engineered CRISPR systems and proteins, associated with a delivery system comprising a virus component and a lipid component. The disclosure includes CRISPR proteins associated with capsid proteins, e.g., AAV VP!, VP2, and/or VP3, on the surface of or internal to the AAV, along with compositions, systems and complexes involving the AAV-CRISPR protein, nucleic acid molecules and vectors encoding the same, deliver}- systems, and uses therefor.
Abstract:
The disclosure includes non-naturally occurring or engineered CRISPR systems and proteins, associated with a delivery system comprising a virus component and a lipid component. The disclosure includes CRISPR proteins associated with capsid proteins, e.g., AAV VP!, VP2, and/or VP3, on the surface of or internal to the AAV, along with compositions, systems and complexes involving the AAV-CRISPR protein, nucleic acid molecules and vectors encoding the same, deliver}- systems, and uses therefor.
Abstract:
Methods for fabricating nanostructures and articles associated therewith are described. In some embodiments, an isolated nanostructure (e.g., a metal nanowire) or an array of nanostructures can be fabricated by depositing a material (e.g., a metal) on a surface having a plurality of protrusions or indentations. At least a portion of the deposited material may be embedded in an encapsulating material, and the encapsulating material can be cut, for instance, to form a thin slice that includes the deposited material at least partially embedded therein. In some instances, the slice can be positioned on a surface in a desired arrangement. The encapsulating material can be removed from the surface to form one or more isolated nanostructures of the deposited material. Advantageously, dimensions of the nanostructures can be controlled to, e.g., 15 run, to form nanostructures having a variety of shapes and geometries (e.g., wires, rings, and cylinders). Nanostructures can also be formed in a variety of materials, including metals, ceramics, and polymers. In addition, nanostructures can also be fabricated over large areas (e.g., greater than 1 mm 2 ). In some cases, these nanostructures are positioned in association with other components, e.g., to form a functional component of a device.
Abstract:
A compound of formula the following formula:(I). In this formula, moieties A, B, X, R 1 , R 2 , and R 3 are defined herein. Also disclosed are a nanocomplex that is formed of such a compound and a pharmaceutical agent, and a nanocomplex that is formed of a protein and a bioreducible compound.